PMID- 35939402 OWN - NLM STAT- MEDLINE DCOM- 20221018 LR - 20221101 IS - 1743-5404 (Electronic) IS - 1743-5390 (Linking) VI - 16 IP - 4 DP - 2022 May TI - Gestational exposure to silver nanoparticles enhances immune adaptation and protection against streptozotocin-induced diabetic nephropathy in mice offspring. PG - 450-471 LID - 10.1080/17435390.2022.2098863 [doi] AB - Silver nanoparticles (AgNPs) possess unique antimicrobial properties. As a result, they are being increasingly used in a wide range of applications. Several studies have shown detrimental effects of AgNPs exposure, including inflammation, accumulation, and cellular damage to different organs. However, the effect of AgNPs exposure during gestation, a critical and susceptible period of human development, on pregnant females and its long-term effects on offspring's health has not been studied. Therefore, we conducted a long-term study where we assessed the effect of gestational AgNPs exposure on pregnant mice and followed their offspring until the age of 12 months. Gestational exposure to AgNPs induced systemic inflammation in the pregnant mice at gestational day (GD) 18. Interestingly, developing fetuses exposed to AgNPs, showed anti-inflammatory conditions as indicated by reduced expression of inflammatory genes in fetal organs at GD 18 and reduced serum levels of TNF-alpha, IFN-gamma, IL-17A, IL-6, and MCP-1 in AgNPs exposed pups at postnatal day (PD) 2. Surprisingly, post-weaning, AgNPs exposed offspring showed a heightened immune activation as shown by upregulation of inflammatory cytokines at PD 28, which persisted till late in life. Moreover, we observed metabolic alterations which persisted until adulthood in mice. To understand the impact of long-term immunometabolic changes on the progression of diabetes and kidney diseases under stressed conditions, we exposed offspring to streptozotocin which revealed a protective role of low-dose gestational AgNPs exposure against streptozotocin-induced diabetes and associated nephropathy. FAU - Tiwari, Ratnakar AU - Tiwari R AD - Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. AD - Department of Biochemistry, School of Dental Sciences, Babu Banarasi Das University, Lucknow, India. AD - Division of Nephrology and Feinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. FAU - Singh, Radha Dutt AU - Singh RD AD - Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. FAU - Singh, Sukhveer AU - Singh S AD - Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. FAU - Singh, Diksha AU - Singh D AD - Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. FAU - Srivastav, Anurag Kumar AU - Srivastav AK AD - Animal House Facility, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. FAU - Kumar, Mahadeo AU - Kumar M AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. AD - Animal House Facility, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. FAU - Srivastava, Vikas AU - Srivastava V AD - Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India. AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220808 PL - England TA - Nanotoxicology JT - Nanotoxicology JID - 101233132 RN - 0 (Cytokines) RN - 0 (Interleukin-17) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 3M4G523W1G (Silver) RN - 5W494URQ81 (Streptozocin) SB - IM MH - Adult MH - Animals MH - Cytokines/genetics/metabolism MH - *Diabetes Mellitus MH - *Diabetic Nephropathies MH - Female MH - Humans MH - Infant MH - Inflammation MH - Interleukin-17 MH - Interleukin-6 MH - *Metal Nanoparticles/toxicity MH - Mice MH - Pregnancy MH - Silver/toxicity MH - Streptozocin MH - Tumor Necrosis Factor-alpha OTO - NOTNLM OT - Silver nanoparticles OT - gestational exposure OT - immunometabolic alterations OT - kidney damage EDAT- 2022/08/09 06:00 MHDA- 2022/10/19 06:00 CRDT- 2022/08/08 13:03 PHST- 2022/08/09 06:00 [pubmed] PHST- 2022/10/19 06:00 [medline] PHST- 2022/08/08 13:03 [entrez] AID - 10.1080/17435390.2022.2098863 [doi] PST - ppublish SO - Nanotoxicology. 2022 May;16(4):450-471. doi: 10.1080/17435390.2022.2098863. Epub 2022 Aug 8.